Paula Desplats
Affiliations: | Neurosciences | University of California, San Diego, La Jolla, CA |
Google:
"Paula Desplats"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gutierrez A, Corey-Bloom J, Thomas EA, et al. (2019) Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients. Frontiers in Molecular Neuroscience. 12: 335 |
| Henderson-Smith A, Fisch KM, Hua J, et al. (2019) DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood. Epigenetics. 1-18 |
| Fields JA, Spencer B, Swinton M, et al. (2018) Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. Journal of Neurochemistry |
| Valera E, Spencer B, Mott J, et al. (2017) MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy. Frontiers in Molecular Neuroscience. 10: 329 |
| Valera E, Spencer B, Fields JA, et al. (2017) Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. Acta Neuropathologica Communications. 5: 2 |
| Cronin P, McCarthy MJ, Lim AS, et al. (2016) Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Wrasidlo W, Tsigelny IF, Price DL, et al. (2016) A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease. Brain : a Journal of Neurology |
| Fields JA, Overk C, Adame A, et al. (2016) Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. Journal of Neuroinflammation. 13: 120 |
| Spencer B, Kim C, Gonzalez T, et al. (2016) α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy Body disease. Human Molecular Genetics |
| Rockenstein E, Desplats P, Ubhi K, et al. (2015) Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease. Journal of Experimental Neuroscience. 9: 131-40 |